[Federal Register Volume 70, Number 97 (Friday, May 20, 2005)]
[Notices]
[Page 29338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-10069]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel, Contract 
Innovative Therapies for Rheumatic and Skin Diseases.
    Date: June 8-9, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Eric H. Brown, MS, PhD, Scientific Review 
Administrator, National Institute of Arthritis, Musculoskeletal & 
Skin Diseases, National Institutes of Health, 6701 Democracy Blvd., 
Room 824, MSC 4872, Bethesda, MD 20892-4872, (301) 594-4955, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-10069 Filed 5-19-05; 8:45 am]
BILLING CODE 4410-01-M